Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B: a Comparison Between Skin-to-Skin Contact, Glucose 25% and Both of Them
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Pain
- Sponsor
- Federal University of São Paulo
- Enrollment
- 640
- Primary Endpoint
- Neonatal pain scales: Neonatal infant pain Scale (NIPS), Neonatal Facial Coding System (NFCS) and Premature Infant Pain Profile (PIPP)
- Status
- Completed
- Last Updated
- 17 years ago
Overview
Brief Summary
Acute procedural pain in neonates may be alleviated by non-pharmacological procedures. This study objective is to test the efficacy regarding pain attenuation of 3 interventions (skin-to-skin contact versus glucose 25% versus skin to skin associated to glucose 25) versus control in healthy newborn infants submitted to intra-muscular vaccination for Hepatitis B at 48-72 hours of life.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Written informed consent.
- •Gestational age of 37 0/7 to 41 6/7 weeks.
- •Patients cared in rooming-in, with post-natal age of 12 to 72 hours of life.
- •Adequate for gestational age and healthy infants.
- •No other painful stimuli before study except for Vitamine K injection soon after birth.
- •Interval from last feeding between 30 and 60 minutes.
Exclusion Criteria
- •Mothers that used opioid at gestation labor or birth.
- •Delivery under general anesthesia.
- •Apgar score less than seven in the 1st or 5th minute of life.
- •Neonates that received any venous, arterial, capillary or spinal puncture.
- •Any congenital malformation or CNS abnormality.
Outcomes
Primary Outcomes
Neonatal pain scales: Neonatal infant pain Scale (NIPS), Neonatal Facial Coding System (NFCS) and Premature Infant Pain Profile (PIPP)
Time Frame: before the pain procedure (atrest), during cleaning of the region, at injection, and 2 minutes after injection
Secondary Outcomes
- Physiologic pain assessment variables: heart rate and oxygen saturation(before the pain procedure (atrest), during cleaning of the region, at injection, and 2 minutes after injection)